IL4I1-driven AHR signature: a new avenue for cancer therapy

IL4I1-driven AHR signature: a new avenue for cancer therapy

Bibliographic Details
Main Authors: Zuli Wang, Tiansheng Li, Chao Mao, Wenliang Liu, Yongguang Tao
Format: Article
Language:English
Published: Nature Publishing Group 2021-03-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-021-00529-z
id doaj-206c7b716de448228ec44fce3ace2fe3
record_format Article
spelling doaj-206c7b716de448228ec44fce3ace2fe32021-03-11T11:45:55ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352021-03-01611210.1038/s41392-021-00529-zIL4I1-driven AHR signature: a new avenue for cancer therapyZuli Wang0Tiansheng Li1Chao Mao2Wenliang Liu3Yongguang Tao4NHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityNHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityNHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South UniversityDepartment of Thoracic Surgery, Hunan Key Laboratory of Early Diagnosis and Precision Therapy in Lung Cancer, Second Xiangya Hospital, Central South UniversityNHC Key Laboratory of Carcinogenesis and Hunan Key Laboratory of Cancer Metabolism, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South Universityhttps://doi.org/10.1038/s41392-021-00529-z
collection DOAJ
language English
format Article
sources DOAJ
author Zuli Wang
Tiansheng Li
Chao Mao
Wenliang Liu
Yongguang Tao
spellingShingle Zuli Wang
Tiansheng Li
Chao Mao
Wenliang Liu
Yongguang Tao
IL4I1-driven AHR signature: a new avenue for cancer therapy
Signal Transduction and Targeted Therapy
author_facet Zuli Wang
Tiansheng Li
Chao Mao
Wenliang Liu
Yongguang Tao
author_sort Zuli Wang
title IL4I1-driven AHR signature: a new avenue for cancer therapy
title_short IL4I1-driven AHR signature: a new avenue for cancer therapy
title_full IL4I1-driven AHR signature: a new avenue for cancer therapy
title_fullStr IL4I1-driven AHR signature: a new avenue for cancer therapy
title_full_unstemmed IL4I1-driven AHR signature: a new avenue for cancer therapy
title_sort il4i1-driven ahr signature: a new avenue for cancer therapy
publisher Nature Publishing Group
series Signal Transduction and Targeted Therapy
issn 2059-3635
publishDate 2021-03-01
url https://doi.org/10.1038/s41392-021-00529-z
work_keys_str_mv AT zuliwang il4i1drivenahrsignatureanewavenueforcancertherapy
AT tianshengli il4i1drivenahrsignatureanewavenueforcancertherapy
AT chaomao il4i1drivenahrsignatureanewavenueforcancertherapy
AT wenliangliu il4i1drivenahrsignatureanewavenueforcancertherapy
AT yongguangtao il4i1drivenahrsignatureanewavenueforcancertherapy
_version_ 1724225145599426560

Similar Items